These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37834118)

  • 1. Long-Term Effects of Suramin on Renal Function in Streptozotocin-Induced Diabetes in Rats.
    Chyła-Danił G; Sałaga-Zaleska K; Kreft E; Stumski O; Krzesińska A; Sakowicz-Burkiewicz M; Kuchta A; Jankowski M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin Affects the Renal VEGF-A/VEGFR Axis in Short-Term Streptozotocin-Induced Diabetes.
    Chyła-Danił G; Sałaga-Zaleska K; Kreft E; Krzesińska A; Herman S; Kuchta A; Sakowicz-Burkiewicz M; Lenartowicz M; Jankowski M
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin enhances the urinary excretion of VEGF-A in normoglycemic and streptozotocin-induced diabetic rats.
    Chyła G; Sałaga-Zaleska K; Dąbkowski K; Kuchta A; Jankowski M
    Pharmacol Rep; 2021 Jun; 73(3):841-846. PubMed ID: 33635529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats.
    Hou N; Huang N; Han F; Zhao J; Liu X; Sun X
    Int Urol Nephrol; 2014 Oct; 46(10):2045-51. PubMed ID: 25118612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of suramin on urinary excretion of diabetes-induced glomerular and tubular injury parameters in rats.
    Sałaga-Zaleska K; Pikul P; Kreft E; Herman S; Chyła G; Dąbkowski K; Kuchta A; Lenartowicz M; Jankowski M
    Biomed Pharmacother; 2021 Jul; 139():111683. PubMed ID: 34243631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
    Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats.
    Shukla R; Pandey N; Banerjee S; Tripathi YB
    Biomed Pharmacother; 2017 Sep; 93():276-285. PubMed ID: 28648975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of VEGF in kidney of diabetic rats].
    Chen ZJ; Yang YB; Huang SM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
    Kakizawa H; Itoh Y; Imamura S; Matsumoto T; Ishiwata Y; Ono Y; Yamamoto K; Kato T; Hayakawa N; Oda N; Goto Y; Goto Y; Nagasaka A; Senda T; Itoh M
    Horm Metab Res; 2004 Jul; 36(7):458-64. PubMed ID: 15305228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes.
    Khamaisi M; Keynan S; Bursztyn M; Dahan R; Reinhartz E; Ovadia H; Raz I
    Nephron Physiol; 2006; 102(3-4):p72-80. PubMed ID: 16319502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride reduces microvessel density and expression of vascular endothelial growth factor in renal tissue of diabetic rats.
    Tian HL; Zhao CX; Wu HY; Xu ZX; Wei LS; Zhao RT; Jin DL
    Am J Med Sci; 2015 Jun; 349(6):516-20. PubMed ID: 25789687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin mediates early phase angiogenesis induced diabetic nephropathy in STZ diabetic rats.
    El Eter EA; Al-Masri AA
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3534-43. PubMed ID: 25491634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.
    Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH
    Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin 1 improves renal function in rats with streptozotocin-induced diabetes by inhibiting overproduction of TGF-beta 1 and VEGF.
    Li X; Hu J; Zhang Q; Sun X; Li S
    Br J Pharmacol; 2009 Jul; 157(6):994-1003. PubMed ID: 19466989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats.
    Qian Y; Li S; Ye S; Chen Y; Zhai Z; Chen K; Yang G
    J Endocrinol Invest; 2008 Dec; 31(12):1069-74. PubMed ID: 19246972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
    Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH
    J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.
    Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W
    J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
    Shevalye H; Stavniichuk R; Xu W; Zhang J; Lupachyk S; Maksimchyk Y; Drel VR; Floyd EZ; Slusher B; Obrosova IG
    Biochem Pharmacol; 2010 Apr; 79(7):1007-14. PubMed ID: 19945439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.